Note 11 - Segments (Tables)

12 Months Ended

Dec. 31, 2022

Notes Tables

Schedule of Segment Reporting Information, by Segment [Table Text Block]

							Year Ended December 31, 2022
	Skyline			Helomics			Soluble			zPREDICTA			Corporate			Total
Revenue	$	1,063,493		$	6,397		$	82,301		$	352,379		$	889		$	1,505,459
Depreciation and Amortization		(28,481	)		(445,686	)		(378,708	)		(390,985	)		(69,215	)		(1,313,075	)
Impairment expense – goodwill		-			-			-			(7,231,093	)		-			(7,231,093	)
Impairment expense – intangibles		-			-			-			(3,349,375	)		-			(3,349,375	)
Impairment expense – Long-lived tangible assets		-			-			(115,775	)		-			(69,694	)		(185,469	)
Net loss	$	(417,774	)	$	(4,122,444	)	$	(1,817,283	)	$	(11,618,762	)	$	(7,761,371	)	$	(25,737,634	)

					December 31, 2022
	Skyline		Helomics		Soluble		zPREDICTA		Corporate		Total
Assets	$	946,394	$	931,721	$	1,353,434	$	123,507	$	22,379,588	$	25,734,644

							Year Ended December 31, 2021
	Skyline			Helomics			Soluble			zPREDICTA			Corporate			Total
Revenue	$	1,169,811		$	13,367		$	233,293		$	90		$	4,119		$	1,420,680
Depreciation and Amortization		(30,002	)		(886,642	)		(366,713	)		(40,625	)		(16,319	)		(1,340,301	)
Impairment expense – goodwill		-			(2,813,792	)		-			-			-			(2,813,792	)
Impairment expense – intangibles		-			(2,893,548	)		-			-			-			(2,893,548	)
Impairment expense – acquired software		-			(1,249,727	)		-			-			-			(1,249,727	)
Net loss	$	(520,822	)	$	(11,326,948	)	$	(1,251,564	)	$	531,446		$	(7,089,286	)	$	(19,657,174	)

					December 31, 2021
	Skyline		Helomics		Soluble		zPREDICTA		Corporate		Total
Assets	$	906,977	$	1,802,792	$	1,742,445	$	10,782,568	$	28,536,489	$	43,771,271